Th-17 response and antimicrobial peptide expression are uniformly expressed in gastric mucosa of Helicobacter pylori-infected patients independently of their clinical outcomes

Helicobacter. 2018 Jun;23(3):e12479. doi: 10.1111/hel.12479. Epub 2018 Mar 27.

Abstract

Background: The pathological determinism of H. pylori infection is explained by complex interplay between bacterial virulence and host inflammatory response. In a large prospective multicenter clinical study, Th17 response, expression of antimicrobial peptides (AMPs), cagA and vacA status, and bacterial density were investigated in the gastric mucosa of H. pylori -infected patients.

Materials and methods: Gastric inflammatory response was analyzed by RT-qPCR for quantification of Th17 cytokines (IL-17A, IL-22), CXCL-8, and AMPs (BD2 and S100A9) mRNA levels in gastric biopsies. Detection and genotyping of H. pylori strains were achieved by bacterial culture and PCR.

Results: Among 787 patients screened for H. pylori, 269 were analyzed (147 H. pylori -infected and 122 uninfected patients). In H. pylori -infected patients, distribution was 83 gastritis, 12 duodenal ulcers, 5 gastric ulcers, and 47 precancerous and cancerous lesions. CXCL-8, IL-17A, BD2, and S100A9 mRNA levels were significantly increased in H. pylori -infected patients but, surprisingly, IL-22 was not, and no difference was shown between H. pylori -related diseases. A positive correlation was identified between S100A9 expression and bacterial density. Although expression of the virulence genes cagA and vacA did not impact inflammatory response, patients infected with a cagA-positive strain were associated with severe H. pylori -related diseases.

Conclusion: This study showed that CXCL-8, IL-17A, and AMPs are not differently expressed according to the various H. pylori -related diseases. The clinical outcome determinism of H. pylori infection is most likely not driven by gastric inflammation but rather tends to mainly influenced by bacterial virulence factors.

Keywords: Helicobacter pylori; clinical trial; cytokine; gastric inflammation; virulence.

Publication types

  • Clinical Study
  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, Bacterial / genetics
  • Antimicrobial Cationic Peptides / genetics
  • Bacterial Proteins / genetics
  • Female
  • Gastric Mucosa / immunology
  • Gastric Mucosa / microbiology*
  • Gastritis / classification
  • Gastritis / immunology
  • Gastritis / microbiology*
  • Helicobacter Infections / immunology
  • Helicobacter Infections / microbiology*
  • Helicobacter pylori / genetics
  • Helicobacter pylori / physiology*
  • Humans
  • Inflammation Mediators / metabolism
  • Male
  • Middle Aged
  • Prospective Studies
  • Young Adult

Substances

  • Antigens, Bacterial
  • Antimicrobial Cationic Peptides
  • Bacterial Proteins
  • Inflammation Mediators
  • VacA protein, Helicobacter pylori
  • cagA protein, Helicobacter pylori